Day One Biopharmaceuticals Inc (DAWN)
16.18
+0.14
(+0.90%)
USD |
NASDAQ |
May 17, 16:00
16.18
0.00 (0.00%)
After-Hours: 20:00
Day One Biopharmaceuticals Accounts Payable (Quarterly): 4.78M for March 31, 2024
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 4.78M |
| December 31, 2023 | 2.576M |
| September 30, 2023 | 3.391M |
| June 30, 2023 | 4.565M |
| March 31, 2023 | 4.657M |
| December 31, 2022 | 0.26M |
| September 30, 2022 | 3.973M |
| Date | Value |
|---|---|
| June 30, 2022 | 0.439M |
| March 31, 2022 | 0.701M |
| December 31, 2021 | 1.744M |
| September 30, 2021 | 0.683M |
| June 30, 2021 | 0.348M |
| March 31, 2021 | 0.686M |
| December 31, 2020 | 0.202M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
0.202M
Minimum
Dec 2020
4.78M
Maximum
Mar 2024
2.072M
Average
1.222M
Median
Accounts Payable (Quarterly) Benchmarks
| Revolution Medicines Inc | 32.38M |
| Zentalis Pharmaceuticals Inc | 10.50M |
| Perspective Therapeutics Inc | 6.027M |
| Electromed Inc | 0.792M |
| Xtant Medical Holdings Inc | 7.378M |